Hematological Malignancies Market to Reach a Value of US$ 51.9 Billion by 2024
The global hematological malignance market is highly competitive in nature with a large number of players operating in it worldwide, states a new research study by Transparency Market Research. In 2015, the leading four players in the market accounted for more than 58% share of the global market and is likely to remain in the similar leading position throughout the forecast period. To expand their product horizon, these players are focusing on extending their products and services in developing economies,...
View full press release